Increased serum or urinary concentrations of neopterin have been described in patients with tumors of different primary locations, but reports on neopterin in patients with esophageal carcinoma are scanty. We have studied serum neopterin, retinol and alpha-tocopherol in 45 patients with carcinoma of the esophagus or gastroesophageal junction. Serum neopterin was determined using radioimmunoassay. Retinol and alpha-tocopherol were determined by high-performance liquid chromatography. Serum neopterin in patients with carcinoma of the esophagus was significantly increased while retinol and alpha-tocopherol were significantly decreased compared to controls. No correlation of neopterin with hemoglobin or peripheral blood cell counts was observed. During chemoradiation, neopterin increased significantly, while retinol and alpha-tocopherol did not change. In conclusion, the present study demonstrates increased serum neopterin and decreased retinol and alpha-tocopherol concentrations in patients with esophageal carcinoma. Chemoradiation induced a further increase of serum neopterin concentrations.
Introduction
In Western countries, esophageal carcinoma is a relatively rare tumor. The mortality of patients affected with esophageal carcinoma is, however, high. Only a minority of patients presents with resectable tumors, and in patients who undergo resection the local and distant recurrence rate is high. Long-term survival may be obtained in only about 20% of patients undergoing radical resection. It has been demonstrated in randomized clinical trials that the administration of chemotherapy combined with external beam radiation increases the resection rate and improves survival compared to patients treated with surgery alone (1) .
Preoperative (neoadjuvant) chemoradiation increases the percentage of radical operations and improves survival, however, at a price of significant toxicity.
Anemia commonly accompanies cancer and antitumor therapy (2) . In many tumors, including esophageal carcinoma, low hemoglobin is associated with poor prognosis. In cancer patients, anemia is usually related to alterations of iron metabolism (3) . In most cases, this is the anemia of chronic disease. An important part in pathogenesis of anemia associated with cancer is played by disorders of iron metabolism associated with systemic inflammatory response that is reflected in increased C-reactive protein or neopterin concentrations (4, 5) . Neopterin is a heterocyclic compound which is primarily produced by human macrophages activated with Th1-type cytokine interferon-gamma. Thus, neopterin is an indicator of systemic immune activation (6) . Increased urinary or serum neopterin concentrations accompany infectious and autoimmune disorders as well as cancer. In patients with cancer increased neopterin is associated with poor prognosis.
In previous studies we have demonstrated that systemic chemotherapy is accompanied by a significant rise in urinary neopterin that indicates systemic immune activation during chemotherapy (7) . The rise of neopterin correlated with other abnormalities, e.g. decreased hemoglobin. Other studies have also confirmed the prognostic significance of neopterin in cancer patients. On the other hand, our knowledge concerning neopterin in esophageal carcinoma is very limited. Neopterin and dihydroneopterin are an oxidant/antioxidant system and changes in neopterin concentrations may be involved, at least partly, in changes of antioxidant equilibrium (8) .
Oxidative equilibrium is also linked to the concentrations of some liposoluble vitamins, e.g. vitamin A or vitamin E (9) . In earlier studies we have demonstrated significant changes in the serum concentrations of vitamins A (retinol) and E (alpha-tocopherol) (10) . Alpha-tocopherol is a major serum antioxidant and changes in the concentrations of these vitamins are also associated with oxidative stress. A decrease of alpha-tocopherol correlated in cancer patients with the presence of systemic inflammatory response, and concentrations increased after chemotherapy (10) . Changes in serum alpha-tocopherol were also associated with differences in the tolerance of chemotherapy (10) . Because of significance of nutritional parameters in patients with esophageal carcinoma it is expected that changes in the concentrations of these vitamins will occur during neoadjuvant chemotherapy that could reflect the course of therapy.
The literature on neopterin as a marker of systemic immune activation in patients with esophageal carcinoma is limited (11) . In the present study, we evaluated serum neopterin, alpha-tocopherol and retinol in patients with esophageal carcinoma. Correlation with hemoglobin and peripheral blood cell counts was also evaluated.
Materials and Methods
Forty-five patients, 10 females and 35 males, aged (mean ± standard deviation) 61 ± 11 (range 36 -85) years, with histologically verified carcinoma of the esophagus, including 12 patients with tumors involving gastroesophageal junction, were included in the study (Table 1) . Seventeen patients had adenocarcinoma, including the 12 patients with tumors involving gastroesophageal junction, and 28 patients had squamous cell carcinoma. Neopterin, retinol and alphatocopherol determination was performed in serum samples obtained for biochemical examination during routine care after the patient consent. The samples were obtained before therapy in 42 patients. Ten patients were examined before and after chemoradiation that included systemic administration of cisplatin and 5-fluorouracil and external beam radiation therapy. In three patients, samples were obtained after chemoradiation. Twenty healthy subjects, 15 females and 5 males, aged 43 ± 12 (range 25 -61) years, served as controls.
The samples were stored at -20 °C until analysis. Neopterin was determined with radioimmunoassay using a commercial kit (BRAHMS, Hennigsdorf, Germany) according to the instructions of the manufacturer. Serum alpha-tocopherol and retinol were determined before and during the therapy by high performance liquid chromatography as described (12) . Blood samples were drawn from a peripheral vein after an overnight fast. The samples were transferred immediately to the laboratory, centrifuged (1600 x g, 10 minutes, 16°C), the serum was separated and frozen at − 20°C until analysis. In the liquid-liquid extraction procedure, 500µl of serum was deproteinized by cool ethanol denatured with 5 % methanol (500µl, 5 minutes, 4°C). Subsequently, 2 500µl of n-hexane was added to this mixture and extracted for 5 minutes by a vortex apparatus. After centrifugation (1 600 x g, 10 minutes, 0°C), the aliquot (2 000µl) of the clean extract was separated and evaporated in a vacuum concentrator (45°C). The residue was dissolved in 400µl methanol and analyzed by reversed-phase high performance liquid chromatography using the external standard calibration. The analyses were performed using the Perkin Elmer high performance liquid chromatography set (Norwalk, USA) comprising of a LC 200 pump, a LC 200 autosampler, LC Column Oven 101 thermostat and LC 235C Diode Array Detector attached to the Perkin Elmer Turbochrom Chromatography Workstation version 4.1. Separation of alpha- tocopherol and retinol was performed using the Chromolith Performance RP-18e, 100 x 4.6 mm monolithic columns (Merck, Darmstadt, Germany). Methanol (100 %) was used as the mobile phase at the flow rate of 2,5 ml.min-1 and column pressure 3.3 MPa. The block heater LC Oven 101 (Perkin Elmer, Norwalk, USA) was utilized to keep the analytical column temperature at 25°C. The injection volume was 50µl. The detection of alpha-tocopherol and retinol was carried out at 295 nm and at 325 nm, respectively. Peripheral blood cell count was performed using Coulter LH 750 (Beckman Coulter, Miami, FL, USA) and Sysmex XE-2100 (Sysmex, Kobe, Japan) hematology analyzers according to the instructions of the manufacturers. Hemoglobin was measured by a photometric method using sodium lauryl sulfate. Leukocytes were detected by flow cytometry method using a semiconductor laser, and platelets by impedance method using hydrodynamic focusing.
Differences of laboratory parameters between groups of patients or controls were analyzed by the Mann-Whitney U test. Differences before and after the therapy were compared by Wilcoxon signed rank test. Correlations were analyzed using Spearman's rank correlation coefficient. The decision on statistical significance was based on p = 0.05 level. The analyses were performed using NCSS software (Number Cruncher Statistical Systems, Kaysville, Utah, USA).
Results
Average serum neopterin concentrations in patients with carcinoma of the esophagus or gastroesophageal junction was significantly increased compared to controls (mean ± standard deviation 7.5 ± 6.4, range 3.7 -46.0 vs. 4.6 ± 0.8, range 3.5 -6.8 nmol/L, p = 0.0002). In contrast, serum alpha-tocopherol and retinol were significantly decreased (18.6 ± 8.0, range 1.7 -37.4 vs. 22.9 ± 6.1, range 14. In 10 patients, samples were obtained before therapy and after chemoradiation and neopterin was significantly increased by treatment, (6.2 ± 2.0 vs. 12.1 ± 4.6 nmol/L, p = 0.005; Fig. 1 ). No such change has been observed in serum alpha-tocopherol and retinol concentrations (12.9 ± 7.2 vs. 15.7 ± 7.5, and 1.09 ± 0.44 vs. 1.15 ± 0.64µmol/L, respectively). Hemoglobin concentration, leukocyte and platelet counts were significantly decreased compared to pre-treatment evaluation (147 ± 13 vs. 115 ± 10 g/L, p <0.01, 8.1 ± 1.6 vs. 5.0 ± 1.8 x 10 9 /L, p = 0.008, and 247 ± 59 vs. 177 ± 53 x 10 9 /L, p <0.05, respectively). In patients serum neopterin correlated significantly with age (r s = 0.65, p <0.00001), and retinol correlated with alpha-tocopherol (r s = 0.54, p <0.001). No other significant correlation was observed between serum neopterin and retinol, alpha-tocopherol and hemoglobin concentrations or leukocyte or platelet counts in patients before therapy or after chemoradiation.
Discussion
Present data demonstrate increased serum neopterin concentrations in patients with esophageal carcinoma. An increase in serum or urinary neopterin concentrations in cancer patients has been amply documented (13, 14) , but little is known about neopterin in patients with carcinoma of the esophagus (11) . In the present study, we demonstrate increased serum concentrations of neopterin in patients with carcinoma of the esophagus or gastroesophageal junction that were accompanied by decreased concentrations of retinol and alphatocopherol. Neopterin is increased in different disorders associated with systemic immune or inflammatory response, therefore determination of neopterin would be of little use in diagnosis. In patients with tumors of different primary locations, increased serum or urinary neopterin concentrations were associated with poor prognosis (13, 14) . In earlier studies, correlations were observed between lower numbers or impaired function of lymphocytes or dendritic cells and increased neopterin concentrations (13) . Thus, increased neopterin concentrations are thought to reflect immune dysregulation. An increase in serum neopterin has been observed in patients treated with chemoradiation indicating that the therapy results in systemic immune activation. Activation of systemic immune or inflammatory response has been earlier reported after the administration of cytotoxic agents (7) or radiotherapy (15) . For example, in patients with breast carcinoma treated with neoadjuvant chemotherapy, we have observed increased urinary neopterin concentrations throughout the course of treatment (7) .
In patients with esophageal carcinoma, increased concentrations of C-reactive protein, a marker of systemic inflammatory response, were reported that were associated with poor prognosis (16) . The number of patients in the present study and short follow up did not allow us to investigate the prognostic significance of serum neopterin concentrations, but the prognostic significance of neopterin in esophageal carcinoma should be addressed in future studies. Nutritional deficiency is common in patients with esophageal carcinoma (17) . Therefore, lower concentrations of retinol and alpha-tocopherol might be expected. No correlation of retinol or alpha-tocopherol was observed with serum neopterin.
A negative correlation between serum neopterin concentrations and hemoglobin has been described in patients with hematological and gynecological malignancies (4, 5) . In the present cohort of patients, anemia was present only in a minority of patients, and mean hemoglobin concentrations indicate that a substantial proportion of patients had hemoglobin concentrations increased above normal range. Low hemoglobin concentrations are associated with poor prognosis in many tumors, but in patients with esophageal carcinoma both high and low hemoglobin predicts poor prognosis (18) . No correlation was observed between hemoglobin and neopterin before or after the treatment, possibly because abnormal hemoglobin concentrations in esophageal carcinoma are observed both in high and low range.
In conclusion, serum neopterin is increased in patients with esophageal carcinoma. A further increase was induced by chemoradiation. Increased neopterin concentrations were accompanied by decreased serum retinol and alpha-tocopherol.
